Improving access to targeted therapies for gynecologic cancer patients
Gynecologic cancer care: Improving clinical trial enrollment through molecular matching with targeted therapies and improving equal access to care and research for all populations
This study is all about helping more people with gynecologic cancers, especially endometrial cancer, find the right treatments by matching them with targeted therapies based on their unique cancer profiles, while also making sure that everyone, especially those from underrepresented groups, has a fair chance to join clinical trials and get the care they need.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-10782742 on NIH RePORTER |
What this research studies
This research focuses on enhancing clinical trial enrollment for gynecologic cancers, particularly endometrial cancer, by utilizing molecular matching to identify suitable targeted therapies. It aims to address the disparities in access to care for underrepresented populations, who often face higher risks and unique subtypes of these cancers. The approach involves increasing awareness and participation in clinical trials among these groups, thereby improving the chances of receiving effective treatments. The study will leverage recent advancements in molecular profiling to ensure that patients are matched with the most appropriate therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients diagnosed with endometrial cancer, especially those from minority groups who may have high-risk subtypes.
Not a fit: Patients with gynecologic cancers who do not have access to clinical trials or those who do not fit the molecular profiles being studied may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved survival rates and better treatment outcomes for patients with gynecologic cancers, particularly those from underrepresented populations.
How similar studies have performed: Other research has shown success in improving clinical trial enrollment through targeted approaches, indicating that this methodology has potential for positive outcomes.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Backes, Floor J. — Ohio State University
- Study coordinator: Backes, Floor J.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.